2m 2m 2m 2m 2m 2m 2m
Target Group (CBDY)
OTC
$0.001+$0.0003 (+33.33%)
Price as of Aug 18, 2026- $740,431.00Market Cap
- -29.41%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Target Group (CBDY)
$0.001+$0.0003 (+33.33%)
CBDY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | +$0.0003 (+33.33%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 100 | ||
30-Day Average Volume | 211,396 | ||
1-Week Change | 0.00% | ||
1-Month Change | 33.33% | ||
1-Year Change | -29.41% | ||
3-Year Change | -83.33% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 617.0M | ||
Total Assets | $5.7M | ||
Market Cap | $740,431.00 | ||
Enterprise Value | $8.1M | ||
Period: QTR TTM FY | |||
Revenue | $1.4M | ||
Net Income | -$239,812.00 | ||
Free Cash Flow | -$229,424.00 | ||
EBIT | -$239,811.00 | ||
EBITDA | -$10,851.00 | ||
Net Working Capital | -$11.2M | ||
EPS | -$0.00 | ||
Enterprise Value/EBITDA | -744 | ||
Enterprise Value/Revenue | 6 | ||
P/B | -0 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue